Vaccines - Netherlands

Netherlands

The Netherlands is projected to witness a substantial growth in revenue within the Vaccines market.
By 2024, the country is expected to reach a revenue of €466.60m.
This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 0.95%.
As a result, the market volume is projected to reach €489.20m by 2029.
In comparison to other countries globally, United States is anticipated to generate the highest revenue in the Vaccines market.
In 2024, United States is projected to generate a revenue of €27,010.00m.
The Netherlands has seen a rise in demand for vaccines, with the government implementing strict regulations to ensure widespread immunization.

Key regions: Australia, Italy, France, South Korea, Brazil

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Netherlands is a small country in Western Europe known for its tulip fields, windmills, and bicycles. However, the country is also known for its advanced healthcare system, which includes a robust vaccination program. The vaccines market in the Netherlands is an important part of the country's healthcare sector, and it is evolving in response to changing customer preferences, local special circumstances, and underlying macroeconomic factors.

Customer preferences: In the Netherlands, customers prefer vaccines that are safe, effective, and affordable. They also prioritize vaccines that protect against common diseases such as influenza, measles, and HPV. In recent years, there has been a growing demand for vaccines that protect against emerging infectious diseases such as COVID-19. This has led to an increase in research and development of new vaccines and therapies.

Trends in the market: The vaccines market in the Netherlands is growing due to several trends. One trend is the increasing prevalence of infectious diseases, which has led to a greater demand for vaccines. Another trend is the adoption of new technologies such as mRNA vaccines, which are more effective and have fewer side effects than traditional vaccines. Additionally, there is a growing trend towards personalized medicine, which involves tailoring vaccines to individual patients based on their genetic makeup and medical history.

Local special circumstances: The Netherlands has a highly developed healthcare system that is funded by a combination of public and private sources. The government plays a significant role in regulating the vaccines market and ensuring that vaccines are safe and effective. Additionally, the country has a strong tradition of scientific research and innovation, which has led to the development of new vaccines and therapies.

Underlying macroeconomic factors: The vaccines market in the Netherlands is influenced by several macroeconomic factors, including population growth, healthcare spending, and government regulations. The aging population is a key driver of demand for vaccines, as older adults are more susceptible to infectious diseases. Additionally, rising healthcare costs and budget constraints are putting pressure on the government to find more cost-effective ways to deliver vaccines to the population. Finally, government regulations play a significant role in shaping the vaccines market, as they determine which vaccines are approved for use and how they are distributed to the population.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.